Current status and perspectives in immunotherapy for metastatic melanoma

Metastatic melanoma was the first malignancy in which immune checkpoint inhibitors demonstrated their successful efficacy. Currently, the knowledge on the interaction between the immune system and malignant disease is steadily increasing and new drugs and therapeutic strategies are overlooking in th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Marconcini, Riccardo, Spagnolo, Francesco, Stucci, Luigia Stefania, Ribero, Simone, Marra, Elena, Rosa, Francesco De, Picasso, Virginia, Di Guardo, Lorenza, Cimminiello, Carolina, Cavalieri, Stefano, Orgiano, Laura, Tanda, Enrica, Spano, Laura, Falcone, Alfredo, Queirolo, Paola
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2018
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5844761/
https://ncbi.nlm.nih.gov/pubmed/29552325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23746
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge